These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 27479652

  • 21. The sensitivity of CD138 immunostaining of bone marrow trephine specimens for quantifying marrow involvement in MGUS and myeloma, including samples with a low percentage of plasma cells.
    Ng AP, Wei A, Bhurani D, Chapple P, Feleppa F, Juneja S.
    Haematologica; 2006 Jul; 91(7):972-5. PubMed ID: 16818287
    [Abstract] [Full Text] [Related]

  • 22. Comparison of bone marrow sections, smears and immunohistological staining for immunoglobulin light chains in the diagnosis of benign and malignant plasma cell proliferations.
    Thiry A, Delvenne P, Fontaine MA, Boniver J.
    Histopathology; 1993 May; 22(5):423-8. PubMed ID: 7688339
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Quantification of bone marrow plasma cell infiltration in multiple myeloma: usefulness of bone marrow aspirate clot with CD138 immunohistochemistry.
    Matsue K, Matsue Y, Kumata K, Usui Y, Suehara Y, Fukumoto K, Fujisawa M, Narita K, Takeuchi M.
    Hematol Oncol; 2017 Sep; 35(3):323-328. PubMed ID: 27140172
    [Abstract] [Full Text] [Related]

  • 26. Morphologic and cytogenetic variables affect the flow cytometric recovery of plasma cell myeloma cells in bone marrow aspirates.
    Cogbill CH, Spears MD, Vantuinen P, Harrington AM, Olteanu H, Kroft SH.
    Int J Lab Hematol; 2015 Dec; 37(6):797-808. PubMed ID: 26224420
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Consensus guidelines on plasma cell myeloma minimal residual disease analysis and reporting.
    Arroz M, Came N, Lin P, Chen W, Yuan C, Lagoo A, Monreal M, de Tute R, Vergilio JA, Rawstron AC, Paiva B.
    Cytometry B Clin Cytom; 2016 Jan; 90(1):31-9. PubMed ID: 25619868
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Single tube, six-color flow cytometric analysis is a sensitive and cost-effective technique for assaying clonal plasma cells.
    Marsee DK, Li B, Dorfman DM.
    Am J Clin Pathol; 2010 May; 133(5):694-9. PubMed ID: 20395515
    [Abstract] [Full Text] [Related]

  • 31. Monoclonal gammopathy of undetermined significance: a morphologic and immunophenotypic study of the bone marrow.
    Feiner HD, Bannan M, Marsh E, Chuba JV, Espiritu E, Gottesman SR.
    Mod Pathol; 1992 Jul; 5(4):372-9. PubMed ID: 1495943
    [Abstract] [Full Text] [Related]

  • 32. Diagnostic utility of bilateral bone marrow examination: significance of morphologic and ancillary technique study in malignancy.
    Wang J, Weiss LM, Chang KL, Slovak ML, Gaal K, Forman SJ, Arber DA.
    Cancer; 2002 Mar 01; 94(5):1522-31. PubMed ID: 11920510
    [Abstract] [Full Text] [Related]

  • 33. Immunophenotypic characterization of bone marrow mast cells in mastocytosis and other mast cell disorders.
    Sánchez-Muñoz L, Teodósio C, Morgado JM, Escribano L.
    Methods Cell Biol; 2011 Mar 01; 103():333-59. PubMed ID: 21722810
    [Abstract] [Full Text] [Related]

  • 34. Immunophenotype of normal vs. myeloma plasma cells: Toward antibody panel specifications for MRD detection in multiple myeloma.
    Flores-Montero J, de Tute R, Paiva B, Perez JJ, Böttcher S, Wind H, Sanoja L, Puig N, Lecrevisse Q, Vidriales MB, van Dongen JJ, Orfao A.
    Cytometry B Clin Cytom; 2016 Jan 01; 90(1):61-72. PubMed ID: 26100534
    [Abstract] [Full Text] [Related]

  • 35. Role of flow cytometry of peripheral blood and bone marrow aspirates in early myeloma.
    Yuan CM, Stetler-Stevenson M.
    Semin Hematol; 2011 Jan 01; 48(1):32-8. PubMed ID: 21232656
    [Abstract] [Full Text] [Related]

  • 36. Artifactual Kappa Light Chain Restriction of Marrow Hematogones: A Potential Diagnostic Pitfall in Minimal Residual Disease Assessment of Plasma Cell Myeloma Patients on Daratumumab.
    Jiang XY, Luider J, Shameli A.
    Cytometry B Clin Cytom; 2020 Jan 01; 98(1):68-74. PubMed ID: 31313879
    [Abstract] [Full Text] [Related]

  • 37. Conventional diagnostics in multiple myeloma.
    San Miguel JF, Gutiérrez NC, Mateo G, Orfao A.
    Eur J Cancer; 2006 Jul 01; 42(11):1510-9. PubMed ID: 16762540
    [Abstract] [Full Text] [Related]

  • 38. Limitations of VS38c labeling in the detection of plasma cell myeloma by flow cytometry.
    Czeti Á, Szalóki G, Varga G, Szita VR, Komlósi ZI, Takács F, Márk Á, Timár B, Matolcsy A, Barna G.
    Cytometry A; 2022 Feb 01; 101(2):159-166. PubMed ID: 34296508
    [Abstract] [Full Text] [Related]

  • 39. Immunophenotypic Heterogeneity of Polytypic Plasma Cells and the Impact on Myeloma Minimal Residual Disease Detection by Multiparameter Flow Cytometry.
    Schouweiler KE, Karandikar NJ, Holman CJ.
    Cytometry B Clin Cytom; 2019 Jul 01; 96(4):310-318. PubMed ID: 31140731
    [Abstract] [Full Text] [Related]

  • 40. Intracellular and extracellular rhomboid shaped crystalline inclusions in a case of IgG lambda restricted plasma cell myeloma: a case report and review of the literature.
    Matoso A, Rizack T, Treaba DO.
    Diagn Pathol; 2010 Jan 21; 5():6. PubMed ID: 20205792
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.